Rimactazid Paed 60/60 is a medication used in the treatment of tuberculosis (TB) in children. It is a combination product containing two active ingredients: Rifampicin and Isoniazid.
Rifampicin is an antibiotic that works by inhibiting the growth of bacteria that cause TB. Isoniazid is also an antibiotic that is effective against TB bacteria.
Dosage and Administration:
The dosage of Rimactazid Paed 60/60 will depend on the weight of the child and the severity of the tuberculosis infection. The medication is available in a fixed-dose combination tablet with 60 mg of rifampicin and 60 mg of isoniazid.
The usual recommended dosage for children is based on body weight:
- For children weighing less than 10 kg: Half a tablet (30 mg rifampicin and 30 mg isoniazid) once daily.
- For children weighing 10 kg or more: One tablet (60 mg rifampicin and 60 mg isoniazid) once daily.
It is important to follow the prescribed dosage and complete the full course of treatment as recommended by the healthcare provider. Rimactazid Paed 60/60 should be taken on an empty stomach, at least one hour before or two hours after a meal, to enhance absorption.
Usage Information:
Rimactazid Paed 60/60 should be taken orally by swallowing the tablet with a glass of water. The tablet should not be crushed or chewed, as this may alter the effectiveness of the medication.
It is essential to adhere to the treatment regimen and take the medication regularly as directed by the healthcare provider. Missing doses or stopping the treatment prematurely can lead to the development of drug-resistant tuberculosis.
Precautions:
Before starting Rimactazid Paed 60/60, inform your healthcare provider about any other medications or supplements your child is taking to avoid potential drug interactions. Additionally, provide information about any existing medical conditions or allergies.
Rimactazid Paed 60/60 may cause side effects in some children, although not everyone experiences them. Common side effects include gastrointestinal disturbances such as nausea, vomiting, and stomach discomfort. If any severe side effects occur, such as severe allergic reactions, jaundice (yellowing of the skin or eyes), or signs of liver problems, seek immediate medical attention.
In conclusion, Rimactazid Paed 60/60 is a combination medication used in the treatment of tuberculosis in children. It contains rifampicin and isoniazid, which are antibiotics effective against TB bacteria. The dosage depends on the child’s weight, and the medication should be taken on an empty stomach. It is important to complete the full course of treatment as prescribed and to inform the healthcare provider about any other medications or medical conditions. If any severe side effects occur, seek medical attention promptly.